Yimin Tang
Shenzhen, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
The dynamic etiology and epidemiological patterns of acute respiratory tract infections during and post non-pharmacological interventions of SARS-CoV-2 in Shenzhen, China: a two years' prospective cohort study from June 2022.
Journal: Frontiers in cellular and infection microbiology
Published: March 25, 2025
Repeated Omicron infection dampens immune imprinting from previous vaccination and induces broad neutralizing antibodies against Omicron sub-variants.
Journal: The Journal of infection
Published: April 26, 2024
A peptide derived from SARS-CoV-2 nucleocapsid protein with broad-spectrum anti-coronavirus activity.
Journal: Journal of medical virology
Published: November 16, 2023
Naive and breakthrough infections with BA.2, BA.5 and BF.7 variants provide poor cross protection against XBB related variants.
Journal: The Journal of infection
Published: May 15, 2023
Efficacy and safety of SIM0417 (SSD8432) plus ritonavir for COVID-19 treatment: a randomised, double-blind, placebo-controlled, phase 1b trial.
Journal: The Lancet regional health. Western Pacific
Published: March 10, 2023
Insights into the Unique Lung Microbiota Profile of Pulmonary Tuberculosis Patients Using Metagenomic Next-Generation Sequencing.
Journal: Microbiology spectrum
Published: February 24, 2022
Regular and booster vaccination with inactivated vaccines enhance the neutralizing activity against Omicron variant both in the breakthrough infections and vaccinees.
Journal: The Journal of infection
Published: December 30, 2021
Pleural IFN-γ release assay combined with biomarkers distinguished effectively tuberculosis from malignant pleural effusion.
Journal: BMC infectious diseases
Published: September 06, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026